Abstract:Insulin is a protein hormone secreted by pancreatic,6 cells. One of its main functions is to keep the balance of glucose inside the body by regulating the absorption and metabolism of glucose in the periphery tissue, as well as the production and storage of hepatic glycogen. The insulin receptor is a transmembrane glycoprotein in which two a subunits with a molecular weight of 135 kD and two beta subunits with a molecular weight of 95 kD are joined by a disulfide bond to form a beta-alpha-alpha-beta structure. The extracellular a subunit, especially, its three domains near the N-terminal are partially responsible for signal transduction or ligand-binding, as indicated by the experiments. The extracellular a subunits are involved in binding the ligands. The experimental results indicate that the three domains of the N-terminal of the a subunits are the main determinative parts of the insulin receptor to bind the insulin or mimetic peptide. We employed the extracellular domain(PDBID: 11GR) of the insulin-like growth factor-1 receptor(IGF-1R) as the template to simulate and optimize the spatial structures of the three domains in the extracellular domain of the insulin receptor, which includes 468 residues. The work was accomplished by making use of the homology program in the Insight U package on an Origin3800 server. The docking calculations of the insulin receptor obtained by homology with hexapeptides were carried out by means of the program Affinity. The analysis indicated that there were hydrogen bonding, and electrostatic and hydrophobic effects in the docking complex of the insulin receptor with hexapeptides. Moreover, we described the spatial orientation of a mimetic peptide with agonist activity in the docking complex. We obtained a rough model of binding of DLAPSQ or STIVYS with the insulin receptor, which provides the powerful theoretical support for designing the minimal insulin mimetic peptide with agonist activity, making it possible to develop oral small molecular hypoglycemic drugs.

The binding potency of lipoic acid modified insulin with insulin receptor

Synthesis, Characterization and Biological Activity of Chemically Modified Insulin Derivative with Alpha Lipoic Acid.

Binding Mode of Insulin Receptor and Agonist Peptide

How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.

How Insulin Binds: the B-Chain α-Helix Contacts the L1 β-Helix of the Insulin Receptor

Investigation of Lectin-Modified Insulin Liposomes As Carriers for Oral Administration

How Insulin Binds to the Insulin Receptor: A Synthetic Chemical Biology Approach

The Effect of Insulin on the Intracellular Distribution of 14(R,S)-[18F]Fluoro-6-thia-heptadecanoic Acid in Rats

[The Enhancing Effect of Tomato Lectin Modified Liposomes of Insulin on Oral Absorption in Mice].

[Interactions of Insulin with Dipalmitoylphosphatidylcholine Liposomes].

Enhanced hypoglycemic effect of biotin-modified liposomes loading insulin: effect of formulation variables, intracellular trafficking, and cytotoxicity.

Study on preparation and unique properties of a novel insulin analogue with N-terminal Arg-4, Pro-3, Lys-2, Pro-1extension at insulin B-chain

Chemical Modification of Insulin by N-phosphorylation

Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.

Mpegylation of Insulin and Characterization of Its Activity

[Preparation of Galactosyl-Insulin with Double Saccharide Density and a Study of Its Hepatic Targeting Property].

Combinatorial libraries of bipodal binders of the insulin receptor

Analysis of Interaction Between Insulin and Its Receptor by Biofunctional Chromatography

[Interaction Between Insulin with Liposome].

The Binding Properties of Insulin Receptor and the Determination of Thiol Group Amounts in Diabetic Rabbits

Hypoglycemic Effect of Intravenous Polyethylene Glycol-Coated Liposomal Insulin on Normal Rats